sumatriptan has been researched along with topiramate in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (33.33) | 29.6817 |
| 2010's | 12 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Verkman, AS; Yang, B; Zhang, H | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Iizuka, T; Sakai, F | 1 |
| Bialer, M; Curtin, C; Doose, DR; Murthy, B; Schwabe, S; Twyman, RE; Wang, SS | 1 |
| Cohen, AS; Goadsby, PJ | 1 |
| Dannenberg, F; Dirnagl, U; Hoffmann, J; Israel, H; Neeb, L; Reuter, U; Triebe, F | 1 |
| Jensen, RH; Tfelt-Hansen, PC | 1 |
| Álvarez, M; Pareja, JA | 1 |
| Kraft, P; Müllges, W | 1 |
| Cady, RK | 1 |
| Csekő, C; Farkas, B; Farkas, S; Kardos, P; Kovács, P; Lendvai, B; Lévay, G; Orosz, S; Tarnawa, I | 1 |
| Ben Aissa, M; Bennett, BM; Bertels, Z; Gaisina, IN; Gandhi, R; Lee, SH; Litosh, V; Moye, LS; Novack, M; Pradhan, AA; Thatcher, GR; Tipton, AF; Wang, Y | 1 |
| Allais, G; Benedetto, C; Chiarle, G; Sinigaglia, S | 1 |
7 review(s) available for sumatriptan and topiramate
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Recent progress in therapy for migraine headache].
Topics: Anticonvulsants; Botulinum Toxins; Calcitonin Gene-Related Peptide; Central Nervous System; Clinical Trials as Topic; Drug Design; Fructose; Humans; Indoles; Meta-Analysis as Topic; Migraine Disorders; Pain; Piperidines; Pyrrolidines; Serotonin Receptor Agonists; Signal Transduction; Sumatriptan; Topiramate; Triazoles; Trigeminal Nerve; Tryptamines; Vasodilation | 2004 |
Pharmacokinetic interactions of topiramate.
Topics: Anticonvulsants; Area Under Curve; Contraceptives, Oral; Drug Interactions; Epilepsy; Fructose; Half-Life; Humans; Lithium; Metabolic Clearance Rate; Psychotropic Drugs; Serotonin Receptor Agonists; Sumatriptan; Topiramate | 2004 |
[Pathophysiology and treatment of trigeminal autonomic cephalalgias].
Topics: Administration, Oral; Amines; Analgesics; Anesthetics, Local; Anti-Inflammatory Agents, Non-Steroidal; Cluster Headache; Cyclohexanecarboxylic Acids; Diagnosis, Differential; Female; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Indomethacin; Lamotrigine; Lidocaine; Male; Methysergide; Nociceptors; Oxygen Inhalation Therapy; Paroxysmal Hemicrania; Serotonin Antagonists; Serotonin Receptor Agonists; Sumatriptan; SUNCT Syndrome; Topiramate; Triazines; Trigeminal Autonomic Cephalalgias; Trigeminal Nerve; Vasoconstrictor Agents; Vasodilator Agents; Verapamil | 2008 |
The usual treatment of trigeminal autonomic cephalalgias.
Topics: Amines; Animals; Cyclohexanecarboxylic Acids; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Lidocaine; Sumatriptan; SUNCT Syndrome; Topiramate; Treatment Outcome; Trigeminal Autonomic Cephalalgias | 2013 |
Chronic migraine in women.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Botulinum Toxins, Type A; Female; Fructose; Humans; Migraine Disorders; Neuroprotective Agents; Serotonin 5-HT1 Receptor Agonists; Sumatriptan; Topiramate | 2014 |
Menstrual migraine: a review of current and developing pharmacotherapies for women.
Topics: Acute Disease; Calcitonin Gene-Related Peptide; Female; Fructose; Humans; Menstruation; Migraine Disorders; Serotonin Receptor Agonists; Sumatriptan; Topiramate; Tryptamines; Vasodilator Agents | 2018 |
11 other study(ies) available for sumatriptan and topiramate
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Lack of aquaporin-4 water transport inhibition by antiepileptics and arylsulfonamides.
Topics: Animals; Anticonvulsants; Aquaporin 4; Biological Transport, Active; Cell Line; Mice; Molecular Structure; Neuroglia; Permeability; Rats; Structure-Activity Relationship; Sulfonamides; Thyroid Gland; Water | 2008 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Intracisternal injection of inflammatory soup activates the trigeminal nerve system.
Topics: Animals; Bradykinin; Calcitonin Gene-Related Peptide; Dinoprostone; Fructose; Histamine; Histamine Agonists; Inflammation; Injections, Intraventricular; Male; Neuroprotective Agents; Oxytocics; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Agents; Serotonin Receptor Agonists; Sumatriptan; Topiramate; Trigeminal Nerve; Vasodilator Agents | 2009 |
Management of cluster headache.
Topics: Analgesics; Cluster Headache; Deep Brain Stimulation; Disease Management; Ergotamine; Fructose; Humans; Hypothalamus; Lithium; Methysergide; Oxygen; Prevalence; Randomized Controlled Trials as Topic; Sumatriptan; Topiramate; Valproic Acid; Verapamil | 2012 |
Musical murmurs on transcranial ultrasound in childhood migraine with aura.
Topics: Anticonvulsants; Basilar Artery; Brain; Child; Echoencephalography; Female; Fructose; Humans; Migraine with Aura; Sumatriptan; Topiramate; Treatment Outcome; Vasoconstrictor Agents | 2013 |
Predictive validity of endpoints used in electrophysiological modelling of migraine in the trigeminovascular system.
Topics: Action Potentials; Animals; Blood Pressure; Disease Models, Animal; Electric Stimulation; Fructose; Heart Rate; Male; Migraine Disorders; Neurons; Neuroprotective Agents; Predictive Value of Tests; Propranolol; Rats; Rats, Wistar; Reaction Time; Sumatriptan; Topiramate; Trigeminal Nerve; Trigeminal Nuclei; Vasodilator Agents | 2015 |
Soluble guanylyl cyclase is a critical regulator of migraine-associated pain.
Topics: Adrenergic beta-Antagonists; Allosteric Regulation; Animals; Anticonvulsants; Calcitonin Gene-Related Peptide; Disease Models, Animal; Enzyme Inhibitors; Female; Hyperalgesia; Male; Mice; Mice, Inbred C57BL; Migraine Disorders; Molecular Targeted Therapy; Nitric Oxide; Nitric Oxide Donors; Nitroglycerin; Oxadiazoles; Propranolol; Proto-Oncogene Proteins c-fos; Quinoxalines; Serotonin 5-HT1 Receptor Agonists; Soluble Guanylyl Cyclase; Sumatriptan; Topiramate | 2018 |